Tag: france

Q&A WITH GENESIS MAGMA RACING DRIVERS ANDR LOTTERER, PIPO DERANI, MATHYS JAUBERT AND DANI JUNCADELLA

Genesis Magma Racing’s four confirmed drivers for the 2026 FIA World Endurance…

TheNewsMarketTeam

Orano: Beginning of a New Phase for the Nurlikum Mining Joint Venture in Uzbekistan

PARIS--(BUSINESS WIRE)--Regulatory News: In September 2025, the state-owned enterprise Navoiyuran (Uzbekistan), the…

Business Wire

Pierre Fabre Laboratories Announces Global Partnership with Know Your Lemons Foundation for Breast Cancer Awareness Month

Innovative Campaign Focuses on Early Detection and Empowering Education Throughout October CASTRES,…

PRNW Agency

Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to…

GlobeNews Wire

MATHYS JAUBERT, DANIEL JUNCADELLA JOIN GENESIS MAGMA RACING WEC DRIVER LINEUP

Mathys Jaubert and Daniel Juncadella have been confirmed as part of Genesis…

TheNewsMarketTeam

GENESIS MAGMA RACING DRIVERS SHOW PACE AND DECISIVE STRATEGY TO SCORE THIRD WIN OF ELMS SEASON AT SILVERSTONE

Genesis Magma Racing Trajectory drivers Jamie Chadwick and Mathys Jaubert, along with…

TheNewsMarketTeam

Rising Star ASTRAUX Shines at IFA Berlin, Accelerates Expansion Across Key EU Markets

BERLIN, Sept. 8, 2025 /PRNewswire/ -- Dubai-based lifestyle tech brand ASTRAUX made…

PRNW Agency

Q&A WITH FX DEMAISON, GENESIS MAGMA RACING TECHNICAL DIRECTOR AND JUSTIN TAYLOR, GENESIS MAGMA RACING CHIEF ENGINEER

Genesis Magma Racing’s technical leads reflect on the busy first weeks of…

TheNewsMarketTeam

OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders Annual General Meeting of September 30, 2025

OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General…

GlobeNews Wire

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by…

PRNW Agency